ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

GRDX vs ABBV // EV/EBITDA & P/E VALUATION

GridAI Technologies Corp. (NASDAQ) VS. AbbVie Inc. (NYSE) • 15-METRIC TALLY: GRDX 0 — ABBV 9
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (GRDX VS. ABBV) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC GRDX ABBV SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin -30.00% 70.20% -100.20 ABBV /gross-margins <GO>
Return on Invested Capital (ROIC) -20.00% 29.00% -49.00 ABBV /roic <GO>
EV/EBITDA & P/E Valuation ACTIVE — 33.3x — TIE /valuation <GO>
Free Cash Flow Yield -14.67% 3.47% -18.14 ABBV /fcf-yield <GO>
Operating Margin -60.00% 24.60% -84.60 ABBV /operating-margins <GO>
Net Profit Margin -60.00% 6.90% -66.90 ABBV /net-margins <GO>
Revenue Growth (YoY) — 8.60% — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 2.27% -2.27 ABBV /dividend-safety <GO>
Altman Z-Score & Debt/Equity — 5.33 — TIE /balance-sheet <GO>
Piotroski F-Score Quality 2/9 7/9 -5.00 ABBV /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 54.5 65.1 -10.55 ABBV /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — 1.15 — TIE /macro-sensitivity <GO>
Forward P/E Multiple — 113.1x — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $38.9M $513.86B -$513.82B ABBV /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR GRDX REV ABBV REV GRDX GROSS % ABBV GROSS % GRDX FCF ABBV FCF
FY 2025 $36.3K $61.16B -50.0% 70.2% -$5.7M $17.82B
FY 2024 $0 $56.33B — 70.0% -$9.2M $17.83B
FY 2023 $0 $54.32B — — -$12.4M $20.39B
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
GRDX // BETA —
ABBV // BETA 1.15